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ABSTRACT: We report a simple temperature-responsive
bioconjugate system comprising superfolder green ﬂuorescent
protein (sfGFP) decorated with poly[(oligo ethylene glycol)
methyl ether methacrylate] (PEGMA) polymers. We used
amber suppression to site-speciﬁcally incorporate the non-
canonical azide-functional amino acid p-azidophenylalanine
(pAzF) into sfGFP at diﬀerent positions. The azide moiety on
modiﬁed sfGFP was then coupled using copper-catalyzed
“click” chemistry with the alkyne terminus of a PEGMA
synthesized by reversible addition−fragmentation chain transfer (RAFT) polymerization. The protein in the resulting
bioconjugate was found to remain functionally active (i.e., ﬂuorescent) after conjugation. Turbidity measurements revealed that
the point of attachment of the polymer onto the protein scaﬀold has an impact on the thermoresponsive behavior of the resultant
bioconjugate. Furthermore, small-angle X-ray scattering analysis showed the wrapping of the polymer around the protein in a
temperature-dependent fashion. Our work demonstrates that standard genetic manipulation combined with an expanded genetic
code provides an easy way to construct functional hybrid biomaterials where the location of the conjugation site on the protein
plays an important role in determining material properties. We anticipate that our approach could be generalized for the synthesis
of complex functional materials with precisely deﬁned domain orientation, connectivity, and composition.
■ INTRODUCTION
Ever since the pioneering work of Davis and co-workers,1,2 the
conjugation of synthetic macromolecules with proteins to
enhance the chemical properties and functions of the latter has
been demonstrated for a variety of systems and a range of
applications. Some illustrative examples include increased
protein activity, proteolytic resistance, and thermal and pH
stability,3,4 properties that have been attributed to the careful
selection of the molecular characteristics of the polymer and the
conjugation site.3 The vast majority of reports involve proteins
conjugated with poly(ethylene glycol) (PEG),5−8 as it is a
biocompatible polymer with a proven record of applica-
tions.3,4,8−11 Noteworthy also is the use of branched PEG
analogues that have been shown to further enhance the
biocompatibility of their protein bioconjugates.12 Nevertheless,
the use of polymers that endow the protein with more intricate
properties has been sought, such as polymers that respond to
external stimuli.13,14
Stimuli-responsive polymers can be used to expand the
properties of protein−polymer systems,15−17 owing to their
ability to change their physicochemical properties as a response
to small changes in their environment (i.e., temperature, pH,
light, etc.) and their corresponding bioconjugates inherit that
ability, obtaining a triggered (and commonly reversible)
amphiphilic character.18−24 Hoﬀman and co-workers pioneered
the use of stimuli-responsive polymers for conjugation with
proteins that allowed their isolation and reuse, or modulation of
their activity.25−29 In other examples, permanently amphiphilic
bioconjugates,18,19,30−32 whereby the protein is conjugated with
a hydrophobic polymer, have shown potential in improving the
protein activity (such as inhibition of tumor cell growth),33
although in some cases the opposite eﬀect was observed.34,35
Similarly, stimuli-responsive bioconjugates (frequently referred
to as “smart” bioconjugates21) are often studied as potential
“on/oﬀ” systems,36−38 whereby the solvation of the polymer
dictates the protein activity.39 In addition to the eﬀect on
protein activity, bioconjugates with an amphiphilic character
(often referred to as “giant amphiphiles”) form elaborate
nanostructures as a result of their self-assembly in
water.30,32,34,40,41
In building protein−polymer macromolecules, several design
decisions must be considered. First, the strategy to attach the
polymer to the protein must be deﬁned. The most used
conjugation method involves the functionalization of all
available natural amino acid target moieties on the protein,42−45
commonly lysine or cysteine residues. Other approaches have
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targeted the N-terminus of the protein,46,47 while in other
examples a single available functional amino acid is
targeted.32,48−51 These synthetic approaches to decorating
proteins have been extensively presented in numerous
noteworthy reviews.6,7,52−63 A recurring limitation in a large
number of the reports in the literature is that covalent coupling
leads to a heterogeneous mixture of products with varying
conjugation degrees. This has been found to be related to the
polymer molecular weight,64 polymer docking location onto the
protein, and also heterogeneities in the protein which aﬀect the
availability of the modiﬁcation sites,65 thus highlighting the
need for complete control over the conjugation site.20
Recent studies have shown that the introduction of
noncanonical amino acids (ncAAs) into a functional protein
expands the available chemistries for conjugation,66 allowing a
higher degree of precision and minimization of side-reactions
and byproducts.67 In one approach, pioneered by Tirrell and
colleagues,68−72 all natural amino acids (typically methionine,
isoleucine, or leucine) are globally replaced by a ncAA. While
powerful, changing all occurrences of a natural amino acid in a
protein may unfavorably aﬀect protein folding and activity. In
addition, the chemical diversity introduced via ncAAs in this
procedure is limited since the ncAA must be a close analogue of
the natural amino acid it replaces. In an alternative approach,
ncAAs are quantitatively installed at deﬁned sites in a protein
through genetic code expansion. The most widely used strategy
for expanding the genetic code is based on the amber
suppression technique using orthogonal aminoacyl-tRNA
synthetase/tRNA pairs.73 Many seminal works from Schultz
and others have established and driven the ﬁeld forward, and
more than 150 diﬀerent ncAAs have been site-speciﬁcally
incorporated into proteins to date.66,74−76 These ncAAs
normally carry functional moieties (e.g., aryl-azide) that do
not exist in the canonical 20 amino acids and that are easy to
chemically modify (e.g., using copper-catalyzed alkyne−azide
cycloaddition77−81), although the success of the modiﬁcation
also relies on the conjugation site.82 A notable example is the
incorporation of a polymerization-initiating ncAA into green
ﬂuorescent protein (GFP) and the subsequent growth of a
polymer from the surface of the protein.83 Such modiﬁcations
can thus allow conjugation with polymers which, as previously
mentioned, could protect the protein from degradation or
prevent the polymer interfering with the protein activity.
Another signiﬁcant advantage of this approach is that it can
allow the introduction of ncAAs without altering the net charge
or the redox potential of the protein, as is often the result of
functionalizing lysine and cysteine residues, respectively.
After deciding how to precisely link proteins to polymers, the
second key design consideration is polymer conjugation
strategy. In one approach, the presynthesized polymer can be
“grafted to” the protein. The major drawback of this approach
stems from the diﬃculty removing the high-molecular-weight
byproducts (i.e., excess polymer). An alternative strategy is to
“graft from”, where the protein is functionalized with a moiety
that participates in the polymer synthesis, such as a polymer-
ization initiator/mediator. Recently, such “grafting from”
approaches have become more accessible since the develop-
ment of reversible deactivation radical polymerizations,57,58
such as atom transfer radical polymerization (ATRP), reversible
addition−fragmentation chain transfer (RAFT) polymerization,
and nitroxide-mediated polymerization (NMP) which allow the
reaction to occur under conditions suitable for retention of the
protein stability.84 However, “grafting to” is still a popular
conjugation method as it allows the ﬁne-tuning of the
molecular characteristics of the polymer before its conjugation.
Recently, several reports have begun to make possible new
types of protein−polymer bioconjugates using GFP as a model
protein.85 Nolte and co-workers, for example, studied the self-
assembly of conjugated biohybrid copolymers comprising GFP
and poly[(oligo ethylene glycol) methyl ether acrylate]
(PEGMA) and showed that the resulting biohybrid amphi-
philes were thermoresponsive.86 However, their study was
limited to the use of natural amino acid handles for conjugation
(i.e., cysteine) and was insuﬃcient to study the impact of
multiple polymers attached to the compact protein core.
Similarly, Olsen et al. reported the conjugation of thermores-
ponsive polymers with a GFP via thiol−maleimide ligation. The
resulting bioconjugates formed micelles when the solution
temperature was increased.87 In another example, Matyjaszew-
ski and co-workers reported the incorporation of pAzF into a
GFP and its subsequent bioconjugation with a PEG containing
two alkyne functionalities. This resulted in a “step-growth”
formation of micron-sized ﬁbers that were attributed to the
dimerization of GFP.88 This was a signiﬁcant advance in the
study of properties of polymer−protein bioconjugates and it
demonstrates the inﬁnite potential applications that will emerge
once more intricate polymers are explored in such systems.
However, our understanding of how the location on the protein
Figure 1. Strategy followed for the synthesis of sfGFP-PEGMA bioconjugates via the engineering of three sfGFP analogues with T216, S2T216, and
S2 site modiﬁcation with pAzF before the CuAAc of alkyne-functional PEGMA (three diﬀerent molecular weights). Upon an increase of the solution
temperature, all bioconjugates were found to aggregate.
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surface of conjugation can aﬀect the resultant properties of the
protein−polymer bioconjugate material remains incomplete.
Here, we sought to build on these recent reports to
demonstrate a simple bioconjugate protein−polymer system
that would allow us to study the impact of site-speciﬁc
conjugation on self-assembly and responsiveness. Our goal was
to produce and study biomacromolecules comprising super-
folder GFP (sfGFP) decorated with temperature-responsive
poly[(oligo ethylene glycol) methyl ether methacrylate]
(PEGMA) chains of diﬀerent molecular weights on more
than one site, by copper-catalyzed azide−alkyne cycloaddition
reaction (CuAAc). Similarly to PEG, PEGMA has been shown
to be biocompatible33 and, additionally, exhibits a lower critical
solution temperature (LCST) in water.89 Our study involved
three steps. First, the sfGFP molecules were functionalized with
azide groups (at amino acid residues 2, 216, or 2 and 216).
Second, the reactive azide moieties were conjugated with an
alkyne-containing PEGMA synthesized by RAFT polymer-
ization. Third, we characterized the reversible transition of the
protein−polymer structures from a water-soluble to a water-
insoluble state upon heating above a critical temperature
(namely the cloud point). Our results showed that the resultant
structures had properties of both the ﬂuorescent sfGFP and the
temperature-responsive PEGMA (Figure 1). Additionally, we
explored the eﬀect of diﬀerent attachment positions on the
protein on the cloud point of the bioconjugate using
turbidimetry, dynamic light scattering (DLS), and small-angle
X-ray scattering (SAXS) analysis.
■ RESULTS AND DISCUSSION
We began our study by producing the p-azidophenylalanine
(pAzF) sfGFP labeled reagents. To incorporate pAzF into
sfGFP, Escherichia coli BL21(DE3) cells were ﬁrst co-trans-
formed with the pEVOL-pAzF plasmid that encodes the
aminoacyl-tRNA synthetase/suppressor tRNA pair90 and an
appropriate mutant pY71-sfGFP plasmid with amber codon
(TAG) at positions of S2, T216, or S2/T216. These locations
were chosen as the S2 and T216 residues are located at
opposite ends of the protein’s barrel structure on ﬂexible loops
that do not aﬀect sfGFP folding. In addition, this design
allowed us to introduce two conjugation points on opposite
sides of the protein structure (Figure 1; see Figure S1 in the
Supporting Information (SI) for more information on the sites
of modiﬁcation).
Then, the desired sfGFP proteins were overexpressed and
puriﬁed from the BL21 (DE3) cells, noting that T7 RNA
polymerase, which drives sfGFP transcription in pY71-sfGFP,
was expressed from a DE3 λ prophage under an isopropyl β-D-
1-thiogalactopyranoside (IPTG)-inducible lacI promoter in
BL21(DE3) (see SI for methods). Protein expression yields
were estimated to be ∼20 mg/L by comparison of puriﬁed
protein to standards of bovine serum albumin at known
concentrations. With the puriﬁed sfGFP variants in hand, we
carried out top-down mass spectrometry (i.e., MS analysis of
whole intact proteins) to detect and provide semiquantitative
information for the incorporation of pAzF into sfGFP. Figure 2
shows the 32+ charge state of sfGFP and clearly illustrates mass
shifts corresponding to the incorporation of each of the
speciﬁcally incorporated pAzF residues. Site-speciﬁc incorpo-
ration of pAzF, as detected by MS, was greater than 95% in all
samples (Figure 2), noting that the experimental and
theoretical protein masses were in good agreement (see SI,
Table S2). In summary, we achieved eﬃcient, high yielding, and
pure site-speciﬁc pAzF incorporation into sfGFP at two
diﬀerent sites at opposite ends of the protein barrel structure.
Once the production of pure modiﬁed proteins by mass
spectrometry was conﬁrmed, the accessibility of the reactive
azide moieties was established by exploration of a CuAAC
reaction with an alkyne-containing rhodamine B ﬂuorescent
dye (1) (see SI). All protein−dye bioconjugates were found to
contain the rhodamine B dye by PAGE analysis (see SI, Figure
S3), although LC-MS suggested incomplete conjugation (see
SI, Figure S4). This highlighted that the two modiﬁed positions
on the sfGFP were accessible for reaction using CuAAC.
For the conjugation of the protein with a polymer, an alkyne-
containing chain transfer agent (CTA, 2) was chosen for the
RAFT polymerization of OEGMA300 (Figure 1). Three
polymers varying in molecular weight (Table 1) were
synthesized by changes in monomer feed and reaction time
Figure 2.Mass spectrum of the 32+ charge state of sfGFP obtained via
top-down mass spectrometry illustrating site-speciﬁc incorporation of
pAzF at single and multiple sites. Major peaks in each spectrum
coincide with the theoretical peaks for each species and have been
highlighted. Smaller peaks to the right of the colored peaks are due to
oxidation of the proteina common electrochemical reaction
occurring during electrospray ionization.91 Water loss events from
the intact sfGFP are detected at minor levels to the left of the major
(colored) peaks. Note that the start (N-terminal) methionine of sfGFP
is usually cleaved post-translationally by methionine aminopeptidase
present in the E. coli proteome. However, the presence of an unnatural
amino acid at S2 appears to hinder this enzyme (For more detail, see
SI Table S2).
Table 1. Number Average Molecular Weights and Molecular
Weight Distributions of the Polymers Used for the Synthesis
of the Bioconjugates
polymer Mn
a (g/mol) ĐM
PEGMA-1 7600 1.26
PEGMA-2 9600 1.32
PEGMA-3 16700 1.36
aDetermined by SEC in THF (2% triethylamine).
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(see SI for synthetic procedure). Overall, the molecular weight
distribution of the polymers was fairly low, while the crucial
presence of the alkyne end-group was conﬁrmed by 1H NMR
spectroscopy (see SI, Figures S6 and S7). It should be noted
that this CTA was chosen as it bears the alkyne functionality on
the R-group, thus permitting the bioconjugation regardless of
the thiocarbonylthio bond stability.92
Conjugation of the alkyne-functional polymers with the
azide-bearing proteins was carried out in Tris buﬀer solution
using copper sulfate as the catalyst, to make a total of nine
protein−polymer structures (three sfGFP constructs plus three
diﬀerent polymer molecular weights). Each bioconjugate was
then puriﬁed by preparative size exclusion chromatography
(SEC), which allowed for assessment of the eﬃciency of the
reaction (Figure 3A). When compared to the unmodiﬁed
sfGFP, all samples were found to exhibit higher molecular
weight peaks, eluting at lower volumes, which were attributed
to the polymer−protein bioconjugates. It should also be noted
that the bioconjugate retention volume decreased with
increasing polymer molecular weight, suggesting that higher
molecular weight polymers resulted in higher molecular weight
bioconjugates. These data conﬁrmed that decoration of site
selective sfGFPs with PEGMA polymers of diﬀerent molecular
weights at both positions 2 and 216 was possible.
To conﬁrm the successful formation of the protein−polymer
bioconjugates, we next carried out SDS-PAGE analysis on the
sfGFP-PEGMA bioconjugates following puriﬁcation by prepa-
rative SEC and sample concentration. Comparison of the
unconjugated sfGFP and the product of the CuAAc reactions
with the diﬀerent molecular weight polymers showed that the
latter exhibit a signiﬁcantly broader band at lower mobility,
consistent with the presence of the bioconjugate (Figure 3B−
D). In the case of PEGMA-1 and PEGMA-2, the broad band
with the highest mobility matches that of the neat polymer and
is attributed to unreacted polymer chains. This is especially
prominent for the PEGMA-1 reactions (Figure 3B), which is
due to the fact that removal from the bioconjugate is more
challenging for the lowest molecular weight polymer sample. In
the case of PEGMA-3, it is hard to determine if there is
unconjugated polymer, as the broad polymer band overlaps
with the molecular weight assigned to the bioconjugate.
However, it was noted that upon heating of these bioconjugate
samples, a precipitate was formed which was determined to be
unreacted PEGMA (see SI, Figure S8) and hence removal of
this by ﬁltration readily allowed for the removal of any
unconjugated polymer.
Following production of protein−polymer bioconjugates, we
then carried out a series of characterization experiments to
assess the impact of conjugation at diﬀerent sites on the protein
surface on the macromolecule properties of the bioconjugates.
First, the activity of the protein−polymer bioconjugates was
compared with that of the wild type nonconjugated sfGFP, in
order to conﬁrm that polymer conjugation does not aﬀect the
inherent ﬂuorescence of the protein.93 To assess activity, we
determined the quantum yield of the sfGFP ﬂuorescence before
and after conjugation (Figure 4).94 Using ﬂuorescein free acid
as the standard, sfGFP was found to have a quantum yield of
0.613 (±0.016). Similarly, the quantum yield of the
bioconjugated sfGFP with PEGMA-2 at the T216 position
(sfGFP(T216)-PEGMA2) was found to be 0.638 (±0.014).
The comparable quantum yields for the bioconjugate and the
sfGFP protein suggest that the ﬂuorophore of the protein is not
Figure 3. Comparison of the synthesized bioconjugates with their corresponding unfunctionalized protein and polymer: (A) Chromatograms from
the crude protein−polymer bioconjugates, and (B) PAGE gels of the proteins upon conjugation with PEGMA-1: lane 1, ladder; lane 2, PEGMA-1;
lane 3, sfGFP(S2); lane 4, sfGFP(S2)-PEGMA1; lane 5, sfGFP(T216); lane 6, sfGFP(T216)-PEGMA1; lane 7, sfGFP(S2T216); lane 8,
sfGFP(S2T216)-PEGMA1; (C) upon conjugation with PEGMA-2: lane 1, ladder; lane 2, PEGMA-2; lane 3, sfGFP(S2); lane 4, sfGFP(S2)-
PEGMA2; lane 5, sfGFP(T216); lane 6, sfGFP(T216)-PEGMA2; lane 7, sfGFP(S2T216); lane 8, sfGFP(S2T216)-PEGMA2; (D) and upon
conjugation with PEGMA-3: lane 1, ladder; lane 2, PEGMA-3; lane 3, sfGFP(S2); lane 4, sfGFP(S2)-PEGMA3; lane 5, sfGFP(T216); lane 6,
sfGFP(T216)-PEGMA3; lane 7, sfGFP(S2T216); lane 8, sfGFP(S2T216)-PEGMA3.
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aﬀected by polymer conjugation, thus conﬁrming that careful
selection of the conjugation site (which is enabled through the
site-speciﬁc incorporation of a ncAA) allows for the retention
of the protein activity. It should be noted that the conjugation
did not have an eﬀect on the sfGFP ﬂuorescence even at
elevated temperatures, as both the bioconjugate and the wild
type sfGFP showed similar ﬂuorescence emissions when cycling
the temperature between 25 and 70 °C (see SI, Figure S9).
Although we did not test the activity of all the protein−polymer
constructs, our data supports an emerging wave of examples
showing the ability to maintain protein activity in protein−
polymer bioconjugates prepared using site-speciﬁcally incorpo-
rated ncAAs.88,93
We then set out to explore the properties of this series of
bioconjugates. First, we wanted to investigate how the
conjugation of a temperature-responsive polymer at diﬀerent
residues in the protein aﬀects the overall bioconjugate thermal
properties. PEGMA is a temperature-responsive polymer with
its transition temperature depending on the PEG side chain
length and the overall polymer molecular weight.89,95 Using
turbidimetry, the cloud point of the neat polymers and all nine
bioconjugates in Tris buﬀer was evaluated (Figure 5). As
expected due to the hydrophobicity of the polymer end group,
the cloud point of the low-molecular-weight PEGMA-1 was at
26.4 °C; however, PEGMA-2 and PEGMA-3 exhibited a
hydrophilic−hydrophobic transition at higher temperatures
(57.8 and 64.5 °C, respectively).
In the case of the proteins conjugated with PEGMA-1, the
cloud point was found to be signiﬁcantly higher than that of the
neat polymer alone, which was attributed to the fact that the
protein provides better water solubility than the end group of
the polymer itself, thus rendering it more hydrophilic. For the
PEGMA-2 and PEGMA-3 bioconjugates, the cloud point was
slightly higher than that of the homopolymers. While the
transition temperature of the bioconjugates varied from 61 to
Figure 4. Normalized absorption and ﬂuorescence emission spectra in
relative units (r.u.) for the sfGFP and the sfGFP PEGMA-2
bioconjugate with pAzF at position T216 (sfGFP(T216)-PEGMA2),
showing retention of the protein ﬂuorescence upon conjugation.
Figure 5. Cloud point curves for the three PEGMA solutions (black lines: squares for PEGMA-1, circles for PEGMA-2, and triangles for PEGMA-3)
and their corresponding bioconjugates with the grafting position being sfGFP(S2) (red lines), sfGFP(T216) (green lines), and both sfGFP(S2T216)
(blue lines), sfGFP (purple line) are also shown for comparison. Note that all measurements are averages of three runs with a standard deviation of
±1 °C.
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67 °C there is a distinct eﬀect on the observed transition
temperature through variation of the polymer molecular weight
and the conjugation site. As such, the shorter polymer
(PEGMA-1) results in bioconjugates that regardless of the
conjugation site become insoluble at almost the same
temperature (63−65 °C). Increasing the molecular weight of
the conjugated polymer (PEGMA-2) results in the hybrid that
is conjugated at the S2 position (sfGFP(S2)-PEGMA2) to
transition at a lower temperature, compared to that conjugated
at the T216 position (sfGFP(T216)-PEGMA2) (ca. 4 °C
lower). Although both positions are located in the ﬂexible loops
of the sfGFP barrel, we suspect that the local environment of
conjugation aﬀects the ability of the PEGMA chains to collapse
upon heating above their cloud point. This is again observed
when comparing the two conjugation sites for the larger
(PEGMA-3) polymers (with a ca. 3 °C diﬀerence between
sfGFP(S2)-PEGMA3 and sfGFP(T216)-PEGMA3). The con-
sistently higher transition temperature for proteins conjugated
at the T216 may be attributed to this site being located in a
more highly charged region of the protein compared to the S2
site. Note that as expected the higher molecular weight
polymer, PEGMA-3, always aﬀorded bioconjugates with higher
transition temperatures compared to the PEGMA-2 conjugates.
Interestingly, the transition temperature for the double-
conjugated sfGFPs with the PEGMA-1 and PEGMA-2
polymers (sfGFP(S2T216)-PEGMA1 and sfGFP(S2T216)-
PEGMA2) occurs at a temperature intermediate to the
observed transition of the single modiﬁed protein bioconju-
gates. In contrast, the transition temperature for the higher
molecular weight polymer (PEGMA-3) conjugated in two
positions (sfGFP(S2T216)-PEGMA3) is slightly lower than
that of the two single-functionalized proteins by ca. 1 °C (for
sfGFP(S2)-PEGMA3) and 3 °C (for sfGFP(T216)-PEGMA3).
This can be attributed to the two polymer chains reaching a
critical molecular weight that allows them to interact and thus
decrease the eﬀective transition temperature, as seen in other
similar bioconjugate systems.96
The increase in turbidity and the absence of macroscopic
precipitation upon heating the bioconjugates above the
transition temperature suggests the formation of dispersed
aggregates whereby the hydrophobic part consists of the
polymer and the hydrophilic is the protein segment of the
bioconjugate. The bioconjugates were thus characterized by
dynamic light scattering (DLS) over a range of temperatures
(Figure 6), whereby upon heating the hydrodynamic size of the
bioconjugates dramatically increased but the unmodiﬁed sfGFP
retained its original size. This supports the hypothesis that due
to the now hydrophobic character of the polymer and the
amphiphilic character of the overall hybrid, the bioconjugates
self-assemble at elevated temperature. It should however be
noted that large aggregate populations were also observed by
DLSregardless of the temperature of the measurement (see
SI, Figures S10−S11)attributed to the presence of aggregates
which were also observed in neat buﬀer. In an attempt to
further conﬁrm the formation of bioconjugate assemblies, the
heated samples were analyzed by transmission electron
microscopy (with the sample preparation taking place at 70
°C, see SI, Figure S12). Unfortunately, only large ill-deﬁned
aggregates could be identiﬁed which were attributed to the
diﬃculty in sample preparation at elevated temperature.
To gain more information on the solution structure of the
protein−polymer bioconjugates, small-angle X-ray scattering
(SAXS) experiments were conducted. Data was collected for
the sfGFP alone, as well as all the bioconjugates at room and
elevated temperature (at 25 and 65 °C). Measurements were
performed using dilute solutions (in all cases less than 0.2 mg/
mL) to minimize the amount of unwanted aggregation. Fitting
analysis (see SI for details) was performed to determine the
radius of gyration Rg and shape of the bioconjugate (see Tables
S3 and S4). As expected, at 25 °C the bioconjugates all had a
larger size than the sfGFP, and furthermore the size of the
bioconjugates in solution increased as the molecular weight of
the conjugated polymer increased.
A Kratky plot (q2I(q) vs q) for each sample was derived, from
the SAXS data, in order to further analyze the bioconjugate
morphology. Such plots are often used to emphasize the
diﬀerences between compact objects such as globular,
structured proteins and that of a random chain, such as an
unfolded protein.97 A bell-shaped curve is obtained in the ﬁrst
case whereas a plateau is found for the second case, and
depending on the local rigidity of the chain, an increase in slope
as q increases may also be observed.97 Such a plot however
suﬀers from limitations as it does not allow direct comparison
of scattering proﬁles of objects of diﬀerent sizes. Moreover, the
Kratky plot of partially folded proteins still shows bell-shaped
curves owing to the presence of structured regions in the
protein. To obviate this problem, a dimensionless Kratky plot
was utilized in this work: the intensity I(q) is normalized to the
forward scattering intensity I(0), which allows comparison of
samples of diﬀerent molecular weights as I(0) is proportional to
the molecular weight; q is normalized to the radius of gyration
of the protein, which makes the angular scale independent of
the protein size.98 Analysis of the dimensionless Kratky plots at
25 °C indicated that the conjugation of the polymer does not
aﬀect the structured domains of the protein for all of the
PEGMA bioconjugates, as the plots at low x-axis values are
similar before and after conjugation (see SI, Figure S13). The
GFP plots show a symmetrical bell-shaped curve as well as a
horizontal asymptote at high x-axis values, characteristic of a
folded protein. The presence of more unstructured domains
after conjugation is proposed as the plots for the bioconjugates
appear to have a higher gradient at high qRg values (qRg > 3).
By SAXS analysis, no signiﬁcant diﬀerence in solution size or
shape for the bioconjugates with diﬀerent site modiﬁcations is
observed (see SI, Table S3). However, the length of the
polymer which is conjugated to the protein has an eﬀect on the
solution structure of the resultant bioconjugate, in that the
Figure 6. Dependence of the hydrodynamic diameter of sfGFP and
the sfGFP(T216)-PEGMA2 bioconjugate on temperature, as
determined by DLS analysis.
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wrapping of the bioconjugated polymers around the protein is
more eﬃcient for the longest polymer, PEGMA-3, as observed
by an increase of the Rg and a more spherical morphology after
bioconjugation (see SI, Table S3).
The dimensionless Kratky plots at elevated temperature 65
°C (close to or above the cloud point of the bioconjugates)
show that the sfGFP is equally or more folded in its native form
than when it is conjugated to the polymers (see SI, Figure S14).
Moreover, the conjugation of the polymers increases the
number of unstructured domains as expected for the
conjugation of a polymer with a random coil conformation in
a collapsed state. The bioconjugates display a more elongated
morphology than the sfGFP at elevated temperature. As the
sfGFP by itself does not exhibit a more elongated morphology,
the elongation is attributed to the polymer chains. This was also
conﬁrmed from analysis of the SAXS curves of the polymers at
diﬀerent temperatures (see SI, Figure S15).
In summary, we have shown the successful incorporation of
an azide-functional ncAA into sfGFP at multiple locations,
synthesizing three sfGFP analogues which could be readily
bioconjugated with one or two alkyne-functional PEGMA
polymers. Our work described the combination of chemical and
biological approaches to produce synthetic protein−polymer
bioconjugates having new structures and reversible self-
assembly properties. The resulting bioconjugates exhibited no
loss in ﬂuorescence, while an increase in temperature resulted
in the reversible increase in turbidity of the bioconjugates
solutions, suggesting the formation of aggregates. Additionally,
the transition temperature was found to be aﬀected by the
molecular weight of the polymer as well as the location of the
polymer conjugation. Finally, we demonstrated that using the
same responsive polymer and conjugating to diﬀerent sites of a
protein leads to no diﬀerence in bioconjugate shape, but it does
lead to a discernible diﬀerence in thermal properties for the
bioconjugates. Our work thus highlights that site-selective
polymer conjugation, which is possible using protein engineer-
ing alongside common conjugation approaches, can be used to
ﬁne-tune functional properties of polymer−protein bioconju-
gates.
Improvements in modiﬁed protein yields will open the way
to even broader applications. For example, amber suppression
technologies in vivo are still generally limited to expression of
proteins containing ncAAs incorporated into a single instance
or few instances within a polypeptide chain.99,100 New
genomically recoded strains101 lacking release factor 1, cell-
free approaches,75,91,93,102,103 and the ability to site-speciﬁcally
incorporate multiple types of ncAAs per protein with high
eﬃciencies promise to make possible novel synthesis
approaches for unique polymeric materials with atomic-scale
resolution over composition, architecture, and functionality.
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Materials and Methods 
Chemicals: 2,2′-Azobis(2-methylpropionitrile) (AIBN) was recrystallized from methanol and stored at 
4 ºC. Poly(ethylene glycol) methyl ether methacrylate (OEGMA300) was purchased from Sigma-
Aldrich and was passed through a basic alumina plug before use. All other chemicals were purchased 
from Sigma-Aldrich and used without further purification. In all experiments a pH 8 Tris-Cl buffer 
was used. The protease inhibitor cocktail was purchased from Thermo Scientific, Strep-tag® 
Purification Columns were obtained from IBA GmbH, Goettingen, Germany. Spin filters (MWCO 10 
kDa) were obtained from Fisher Scientific. 
Synthesis of N-(6-(diethylamino)-9-(2-((prop-2-yn-1-yloxy)carbonyl)phenyl)-3H-xanthen-3-ylidene)-
N-ethylethanaminium (dye (1)). 
 
In an ice cold round-bottom flask propargyl alcohol (81 μL, 1.392 mmol, 1 eq.), rhodamine B (1g, 
2.088 mmol, 1.5 eq.), N,N'-dicyclohexylcarbodiimide (310.2 mg, 1.503 mmol, 1.08 eq.) were 
dissolved in 50 mL dichloromethane (CH2Cl2) before the addition of 4-(dimethylamino)pyridine 
(11.1 mg, 0.090 mmol, 0.065 eq.). The reaction was allowed to warm to room temperature and was 
stirred overnight. The precipitates were removed by filtration and the solvent was removed under 
reduced pressure. The product, dye (1), was isolated as a dark purple-green solid after purification by 
column chromatography (382 mg, 57% isolated yield). TLC analysis (CH2Cl2:methanol 9:1): Rf = 
0.43; 
1
H NMR (300 MHz, CDCl3): δ (ppm) 8.29 (m, 1H, Ar), 7.80 (m, 1H, Ar), 7.72 (m, 1H, Ar), 
7.31 (m, 1H, Ar), 7.03 (d, J = 9.5 Hz, 2H, Ar), 6.87 (dd, J = 2.4, 9.5 Hz, 2H, Ar), 6.80 (d, J = 2.4 Hz, 
2H, Ar), 4.59 (d, J = 2.4, 1H, -OCH2-), 3.57-3.65 (q, J = 7.1 Hz, 8H, CH2-CH3), 2.39 (t, J = 2.4 Hz, 
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1H, C≡CH), 1.29 (t, J = 7.1 Hz, 12H, CH3); 
13
C NMR (125 MHz, MeOD): δ (ppm) 113.7, 112.9, 95.8, 
76.3, 75.3, 52.3, 45.6, 12.1; HRMS (m/z): expected, 481.2486; found, 481.2492 [M]
+
. 
Synthesis of prop-2-yn-1-yl 2-phenyl-2-((phenylcarbonothioyl)thio)acetate (2). 
 
The synthesis of the alkyne chain transfer agent (CTA) was concluded in 3 steps, based on procedures 
from the literature.
1
 For the first step, α-bromophenyl acetic acid (5g, 23.25 mmol, 1 eq.) was added to 
thionyl chloride (12.6 mL, 172.81 mmol, 7.4 eq.) and the mixture was refluxed under nitrogen for 2.5 
hours. Excess reagents and by-products were removed by distillation at room temperature to yield a 
brown oil that was used without further purification.  
For the second step, in a dry round bottom flask, propargyl alcohol (6.77 mL, 116.21 mmol, 5 eq.) and 
triethylamine (6.48 mL, 46.5 mmol, 2 eq.) were dissolved in dry dichloromethane (25 mL) and purged 
with nitrogen before the brown oil was added dropwise. The mixture was stirred overnight before 
washing with 0.1M HCl, followed by water, then saturated NaHCO3, and finally again with water. 
The organic layer was then dried over MgSO4. The pure product prop-2-yn-1-yl 2-bromo-2-
phenylacetate was isolated by flash chromatography (2.8 g, 48% isolated yield). TLC (CH2Cl2:Pet 
Ether): Rf = 0.73; 
1
H NMR (300 MHz, CDCl3): δ (ppm) 7.39 (m, 2H, Ar), 7.24 (m, 3H, Ar), 5.25 (d, J 
= 2.5 Hz, 1H, -CH-Br), 4.61 (m, -O-CH2-, 2H), 2.36 (m, 1H, ≡CH); 
13
C NMR (75 MHz, CDCl3): δ 
(ppm) 167.6, 135.3, 129.5, 128.7, 128.0, 76.5, 75.9, 53.7, 45.9. 
For the third step,
2
 phenyl magnesium bromide (3M solution in diethyl ether, 2.95 mL, 8.84 mmol, 
1 eq.) was added to a dry round bottom flask containing dry THF (9 mL). The mixture was heated to 
40 ºC before the slow addition of carbon disulfide (532 μL, 8.84 mmol, 1 eq.). Then, the previously 
synthesized prop-2-yn-1-yl 2-bromo-2-phenylacetate (2.35 g, 9.29 mmol, 1.05 eq.) was added and the 
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reaction was allowed to proceed overnight at 80 ºC. Upon cooling down, 20 mL of ice-cold water was 
added and the organic layer was extracted with diethyl ether three times. The combined ether phases 
were washed with water and dried over MgSO4. The product was purified by flash chromatography 
(1.33g, 46% isolated yield). TLC (Et2O:Pet ether 1:2): Rf = 0.54; 
11
H NMR (300 MHz, CDCl3) δ 
(ppm) 7.98 (dd, J = 1.1, 8.4 Hz, Ar, 2H), 7.44 (m, Ar, 8H), 5.71 (s, -S-CH-, 1H), 4.74 (m, CH2, 2H), 
2.47 (d, J = 2.5, ≡CH, 1H); 13C NMR (125 MHz, MeOD) δ (ppm) 226.3, 168.1, 143.9, 132.7, 132.6, 
129.0, 128.9, 128.6, 128.5, 128.3, 76.6, 45.5, 58.5, 53.0; HRMS (m/z): expected, 349.0327; found, 
349.0325 [M+Na]
+
. 
Synthesis of alkyne-functional poly[(oligo ethylene glycol) methyl ether methacrylate] (PEGMA). For 
a typical polymerization, AIBN (1.2 mg, 7 μmol, 0.1 eq.), 2 (22.8 mg, 70μmol, 1 eq.), and the 
monomer OEGMA300 (2 mL, 7 mmol, 100 eq.) were dissolved in dioxane (4 mL) and degassed by 
three freeze-pump-thaw cycles. The ampoule was then charged with nitrogen and the reaction was 
stirred for three hours at 65 ºC. The polymer was isolated via precipitation in cold hexane, followed 
by dialysis against pure water to remove excess monomer. 
 
Table S1. Reagent quantities and conditions used for the synthesis of the alkyne-functional polymers 
PEGMA-1, PEGMA-2, and PEGMA-3. 
PEGMA-1 PEGMA-2 PEGMA-3
m (g) 2.0 1.0 2.0
n (mmol) 6.670 3.334 6.670
eq. 50 50 100
m (mg) 43.2 21.6 22.8
n (mmol) 0.132 0.066 0.070
eq. 1 1 1
m (mg) 2.2 1.1 1.2
n (mmol) 0.013 0.007 0.007
eq. 0.1 0.1 0.1
dioxane V (mL) 4 2 4
time (h) 2 2.5 3
OEGMA300
2
AIBN
 
Protein expression, purification, and mass spectrometry analysis. 
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The super folder green fluorescent protein (sfGFP) construct was that reported by Hong.
3
 The 
sequence encoding the sfGFP variant is shown here (with the S2 and T216 highlighted in red): 
M  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G 
D  V  N  G  H  K  F  S  V  R  G  E  G  E  G  D  A  T  I  G 
K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P  T  L 
V  T  T  L  T  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  R 
H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  S  F 
K  D  D  G  K  Y  K  T  R  A  V  V  K  F  E  G  D  T  L  V 
N  R  I  E  L  K  G  T  D  F  K  E  D  G  N  I  L  G  H  K 
L  E  Y  N  F  N  S  H  N  V  Y  I  T  A  D  K  Q  K  N  G 
I  K  A  N  F  T  V  R  H  N  V  E  D  G  S  V  Q  L  A  D 
H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y 
L  S  T  Q  T  V  L  S  K  D  P  N  E  K  G  T  R  D  H  M 
V  L  H  E  Y  V  N  A  A  G  I  T  W  S  H  P  Q  F  E  K 
 
 
 
 
Figure S1. Surface charge of sfGFP calculated using APBS and rendered in PyMol. Residues 210-
215 displayed in top left panel in pink with spheres. Serine 2 displayed in bottom panel in pink. 
Surfaces are displayed as 40% opaque. Blue color: Positive charge; Red color: Negative charge. 
Based on the surface Figure, we can conclude that T216 site is more accessible than S2 site. Please 
note that the Figure is generated based on the original sfGFP amino acid sequence (PDB:2B3P), not 
our currently used sfGFP (which has 2 further amino acids G and T inserted between the K216 and 
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R215 sites). Therefore the original site R215 becomes current site R217. The inserted G is now at site 
215 and T is at the site 216. 
 
To incorporate the non-natural amino acid p-azidophenylalanine (pAzF) into the super folder green 
fluorescent protein (sfGFP), E. coli BL21(DE3) cells were co-transformed with the pEVOL-pAzF 
plasmid that encodes the aminoacyl-tRNA synthetase/suppressor tRNA pair
4
 and the appropriate 
mutant pY71-sfGFP plasmid (pY71-sfGFP-S2TAG, pY71-sfGFP-T216TAG or pY71-sfGFP-
S2TAG/T216TAG). All sfGFP mutants were C-terminally Strep-tagged for purification. Cells were 
grown overnight at 37 °C in 20 mL LB medium supplemented with chloramphenicol (34 μg/mL) and 
kanamycin (50 μg/mL). Of the overnight culture, 15 mL was used to inoculate 500 mL of LB in a 
2.5-L flask containing appropriate antibiotics. After incubation at 37 °C and 250 rpm for 1 h, 5 mL of 
pAzF (500 mM) was added to the culture given a final concentration of 5 mM. After 30 min, protein 
expression was induced by addition of arabinose and IPTG to final concentrations of 0.1% and 5 mM, 
respectively. After overnight induction, cells were harvested by centrifugation at 6,000 g and 4 °C for 
15 min. The cell pellets were washed once with 20 mL phosphate buffered saline (PBS buffer, pH 
7.4) and then centrifuged at 5,000 g and 4 °C for 10 min. The washed pellets were resuspended in 4 
mL of PBS buffer plus 50 μL protease inhibitor cocktail and lysed on ice by sonication for three 
pulses (50% amplitude, 45 s on and 59 s off). The lysate was clarified by centrifugation for 10 min at 
12,000 g and 4 °C. Proteins were purified from the supernatant by 1-mL Strep-tag® Purification 
Columns according to the manufacture’s protocol. Purified proteins were analyzed by 4-12% 
NuPAGE SDS-PAGE gels. Yields of purified proteins were determined by the Quick-Start Bradford 
Protein Assay Kit (Bio-Rad). 
The purified and modified proteins were analysed by LC-MS using a 100 mm × 75 μm ID PLRP-S 
column in-line with an Orbitrap Elite (ThermoFisher, Waltham, MA). All MS methods included the 
following events: 1) FT scan, m/z 400−2,000, 120,000 resolving power and 2) data-dependent 
MS/MS on the top 2 peaks in each spectrum from scan event 1 using higher-energy collisional 
dissociation (HCD) with normalized collision energy of 25, isolation width 50 m/z, and detection of 
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ions with resolving power of 60,000. All data were analyzed using QualBrowser, part of the Xcalibur 
software packaged with the ThermoFisher Orbitrap Elite. 
Conjugation of dye(1) with sfGFP-azide to yield the sfGFP-dye(1) bioconjugates. In a typical reaction 
250 μL of the mono-azide functional sfGFP solution (1.125 mg, 41.7 nmol) was stirred overnight with 
250 μL of a freshly prepared Tris buffer solution containing the dye(1) (0.216 mg, 0.416 μmol, 10 
eq.), tris-(hydroxypropyltriazolylmethyl)amine (THPTA) (0.905 mg, 2.08 μmol, 50 eq.), (+)-sodium 
L-ascorbate (4.13 mg, 20.83 μmol, 500 eq.), and CuSO4·5H2O (0.104 mg, 0.42 μmol, 10 eq.). Excess 
dye was then removed by consecutive spin filtration-addition of fresh buffer cycles until the filtrate 
was clear. For conjugation of the dye(1) to the di-azide functional sfGFP, all reagents were doubled in 
quantity. 
Conjugation of PEGMA with sfGFP-azide to yield the sfGFP-PEGMA bioconjugate. In a typical 
reaction 200 μL of the mono-azide functional sfGFP solution (0.878 mg, 32.5 nmol) were stirred 
overnight with 200 μL of a freshly prepared buffer solution containing PEGMA-1 (24.8 mg, 3.25 
μmol, 100 eq.), tris-(hydroxypropyltriazolylmethyl)amine (THPTA) (0.706 mg, 1.63 μmol, 50 eq.), 
(+)-sodium L-ascorbate (3.2 mg, 16.26 μmol, 500 eq.), and CuSO4·5H2O (0.081 mg, 0.33 μmol, 10 
eq.). For conjugation of PEGMA to the di-azide functional sfGFP, all reagents were doubled in 
quantity. The pure bioconjugates were isolated initially by SEC in order to remove low molecular 
weight impurities and excess sfGFP. Excess polymer was then removed by thermal precipitation. 
Analytical methods for characterizing protein, polymers, and the bioconjugates. Nuclear magnetic 
resonance (
1
H and 
13
C NMR) spectra were recorded on a Bruker AC-250, a Bruker DPX-300, a 
Bruker AV-400 or a Bruker DPX- 400, a Bruker AV-500, and a Bruker AV II-700 spectrometer. 
Chemical shifts are reported as δ in parts per million (ppm) and referenced to the chemical shift of the 
residual solvent resonances (CDCl3 
1H: δ = 7.26 ppm; 13C: δ = 77.2 ppm; MeOD 1H: δ = 4.78 ppm, 
13
C: δ = 49.3 ppm). High resolution mass spectra (HRMS) were collected using a Bruker MaXis 
UHR-ESITOF. Dynamic light scattering measurements were conducted on a Malvern Zetasizer 
equipped with a 632 nm laser source and a fixed angle detector (172 
o
) and analysed using v6.20 
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software. Aqueous size exclusion chromatography was performed on a GE Healthcare AKTA-Purifier 
equipped with a HiLoad Superdex 75 PG column and a fraction collector, operating at 4 ºC. SEC 
measurements were carried out on an Agilent 390-MDS equipped with differential refractive index 
and UV detectors. The separation was achieved by a guard column (Varian PLGel 5 μm) and two 
mixed-D columns (Varian PLGel 5 μm) using THF (2% TEA mixture) as the eluent at a flow rate of 
1 mL/min. Data analysis was performed using Cirrus v3.3 with calibration curves produced using 
Varian Polymer laboratories Easi-Vials linear poly(methyl methacrylate) standards. Fluorescence 
spectra were recorded on a single beam Perkin Elmer LS55 fluorometer. UV/vis spectroscopy was 
carried out on a Perkin Elmer Lambda 35 UV/vis spectrometer, equipped with a PTP-1+1 Peltier 
temperature programmer. For the cloud point measurements the absorbance of the samples at λ = 600 
nm was measured as a function of the solution temperature. Each sample was measured three times. 
Transmission electron microscopy was performed on a JEOL 2000FX in bright field mode. The 
samples were prepared as follows: the bioconjugates were diluted 100 fold in buffer and heated to 75 
ºC on a hot plate before deposition of 4 μL onto a graphene oxide TEM grid (also heated to 75oC 
before deposition of the sample droplet). After the drop dried, the grid was rinsed five times with pre-
heated deionized water to remove buffer salts before allowing cooling down.  
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Supplementary Characterization Tables and Figures 
Table S2. Monoisotopic masses of sfGFP species calculated from mass spectrometric data. Masses 
calculated from MS data are marked as “experimental”, while masses calculated based on the 
sequence of the proteins are marked as “theoretical”. The start (N-terminal) methionine of sfGFP is 
usually cleaved post-translationally by methionine aminopeptidase present in the E. coli proteome. 
However, the presence of an unnatural amino acid at S2, appears to hinder this enzyme. 
GFP species 
Mass 
(Da, 
Experimental) 
Mass 
(Da, 
Theoretical) 
error 
(ppm) 
Shift from 
WT-sfGFP 
(Da, Experimental) 
Shift from 
WT-sfGFP 
(Da, Theoretical) 
WT-sfGFP
a
 26847.52 26847.45 2.6 -- -- 
sfGFP(T216)-
pAzF
a 26934.57 25934.47 3.5 87.12 87.02 
sfGFP(S2)-
pAzF 
27079.67 27079.53 5.1 232.22
b
 232.08
b 
sfGFP(S2T216)-
pAzF 
27166.67 27166.55 4.3 319.22
b 
319.10
b 
a
start methionine has been cleaved 
b
mass shift includes the mass of the start methionine residue (131.0405Da) 
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Fluorescence of the sfGFP-dye bioconjugates 
500 550 600 650
 
 
 
Wavelength (nm)
 sfGFP
 dye (1)
 sfGFP(S2)-dye(1)
 sfGFP(T216)-dye(1)
 sfGFP(S2T216)-dye(1)
 
Figure S2. Fluorescence emission spectra for the native sfGFP and the three sfGFP-dye(1) 
bioconjugates excited at 470 nm, and free dye(1) excited at 550 nm. After extensive purification of 
the three dye-coupled protein samples, they were examined by fluorescence and the intrinsic activity, 
as indicated by the protein fluorescence, was preserved. As expected, when excited at 470 nm the 
anticipated emission maximum at 507 nm was observed and in addition, a new emission peak at 580 
nm was also observed, attributed to the bioconjugated rhodamine moiety. 
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PAGE analysis of sfGFP-dye(1) bioconjugates 
 
Figure S3. PAGE gel of the protein-dye bioconjugates visualized by ruby red fluorescence: lane 1 – 
ladder, lane 2 – wtsfGFP, lane 3 – wtsfGFP mixed with dye(1), lane 4 – sfGFP(T216), lane 5 – 
sfGFP(T216)-dye(1), lane 6 – ladder, lane 7 – sfGFP(S2), lane 8 – sfGFP(S2)-dye(1), lane 9 – blank, 
lane 10 – sfGFP(S2T216), lane 11 – sfGFP(S2T216)-dye(1). 
 
 
LC-MS of sfGFP-dye(1) bioconjugates 
 
Figure S4. LC-MS of the sfGFP(S2)-dye(1) bioconjugate. The successful conjugation of the dye onto 
the protein species was also confirmed by LC-MS whereby a new peak at higher retention times was 
observed.  
1 2 3 4 5 6 7 8 9 10 11
sfGFP(S2)-pAzF 
sfGFP(S2)-dye(1) 
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MS of sfGFP modified with pAzF and the sfGFP-dye(1) bioconjugate 
 
Figure S5. Mass spectra of the sfGFP modified with pAzF at position S2 (sfGFP(S2)-pAzF), and the 
corresponding GFP-dye bioconjugate (sfGFP(S2)-dye(1)). Major peaks in each spectrum coincide 
with the theoretical peaks for each species and have been highlighted. Smaller peaks to the right of 
the major peaks are due to oxidation of the protein—a common electrochemical reaction occurring 
during electrospray ionization. The theoretical mass distribution of the functionalized protein matches 
the experimental, thus confirming the presence of the protein-dye bioconjugate and therefore the 
accessibility of the S2 residue towards conjugation. 
  
Experimental 
sfGFP(S2)-pAzF 
 
Theoretical  
sfGFP(S2)-pAzF 
Experimental  
sfGFP(S2)-dye(1) 
 
Theoretical  
sfGFP(S2)-dye(1) 
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SEC chromatograms of the alkyne-functional polymers 
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Figure S6. SEC chromatograms (THF (2% triethylamine) with PMMA standards) for the three 
alkyne-functional polymers (green: PEGMA-1, red: PEGMA-2, blue: PEGMA-3) 
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1
H NMR spectroscopy of the alkyne-functional polymer 
 
Figure S7. 1H NMR spectrum of PEGMA-1 in MeOD showing the characteristic signals for the 
corresponding highlighted end-group protons. While the alkyne proton signal was not visible, as it 
overlapped with the polymer repeat unit signals, the integration comparison of the aromatic protons 
(at ca. 8.2 ppm) and the CH2 next to the alkyne (at ca. 4.7 ppm) suggests the presence of the alkyne 
end group in each of the polymer samples. 
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Purification of the bioconjugates / removal of excess polymer 
For the purification of the bioconjugates and the removal of excess polymer, the solutions were heated 
to 70 ºC and the green-cloudy supernatant was isolated and used for further analyses. The pink 
precipitate was isolated and found to be PEGMA homopolymer by 
1
H NMR spectroscopy. 
 
Figure S8. Photograph showing the observed pink precipitate and the corresponding 
1
H NMR 
spectrum, highlighting the characteristic peaks of the PEGMA homopolymer, which was isolated 
following slow heating of the bioconjugate solution. 
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Fluorescence cycling with temperature 
The effect of increased temperature on the bioconjugates was also examined by measuring the 
fluorescence intensity upon heating to 70 ºC. At elevated temperature the unmodified sfGFP and the 
sfGFP(T216)-PEGMA2 bioconjugate fluorescence (Figure S9) had significantly decreased, however, 
upon re-cooling to room temperature the initial fluorescence was almost completely regained in both 
cases. After multiple heating-cooling cycles, the emission intensity had significantly dropped for both 
samples; however in the case of the bioconjugate the drop was more prominent. This may be 
attributed to the fact that upon heating the polymer becomes hydrophobic, creating a hydrophobic 
environment on the surface of the protein that was previously hydrophilic, thus disrupting the protein 
folding and resulting in the loss of fluorescence upon repeated temperature cycling. It is noteworthy 
that this effect is only significant after six heating cycles (that correspond to ~ 1 hour total heating).  
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Figure S9. Plot of the fluorescence maxima intensity (λex = 470 nm, λem = 507 nm) of the unmodified 
sfGFP and the sfGFP(T216)-PEGMA2 bioconjugate as a function of temperature upon multiple 
heating-cooling cycles. 
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Turbidimetry studies of the polymer and bioconjugates cloud point 
300 μL of the bioconjugate solution was diluted with an equal amount of Tris buffer before placing in 
a UV cuvette. The sample absorption at 600 nm was measured while increasing the temperature using 
a 1 ºC/min ramp. Each sample was measured three times and the individual runs were averaged. 
 
Characterization of the bioconjugates by DLS and TEM analysis 
Dynamic light scattering (DLS) measurements 
For the determination of the hydrodynamic size of the proteins and the bioconjugates, 10 μL of the 
solution was diluted with 2 mL of buffer or water. The measurements were recorded in triplicate at 
temperatures ranging from 5-70 ºC. Due to the scattering of the buffer, the results were analyzed by 
fitting of a stretch exponential decay function to the correlation function and elimination of the 
processes corresponding to the buffer scattering.
5
 In order to confirm the outcome, the measurements 
were repeated in water with no corrections. While the number-based size distributions only showed 
small particles, large aggregates were still observable in the intensity-based distributions.  
1 10 100 1000 10000
0
5
10
15
20
25
30
35
 
 
N
u
m
b
er
 (
%
)
D
h
 (nm)
   5
o
C
 20
o
C
 35
o
C
 50
o
C
 65
o
C
 68
o
C
 70
o
C
1 10 100 1000 10000
0
5
10
15
20
 
 
In
te
n
si
ty
 (
%
)
D
h
 (nm)
   5
o
C
 20
o
C
 35
o
C
 50
o
C
 65
o
C
 68
o
C
 70
o
C
 
Figure S10. Size distributions by number (left) and intensity (right) for the sfGFP(T216)-PEGMA2 
bioconjugate at different temperatures. 
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Figure S11. Hydrodynamic diameters (number averaged) of the sfGFP(T216)-PEGMA2 bioconjugate 
as a function of temperature, measured in water. 
  
TEM imaging of the bioconjugates at elevated temperatures 
  
Figure S12. TEM images of the sfGFP(S2)-PEGMA1 bioconjugate (A), sfGFP(S2)-PEGMA2 
bioconjugate (B), and sfGFP(S2)-PEGMA3 bioconjugate (C), as well as the bifunctional 
sfGFP(S2T216)-PEGMA2 bioconjugate (D) prepared at temperatures above the cloud point of the 
bioconjugates. The bioconjugates were imaged on graphene oxide grids without staining (Scale bars: 
200 nm).
6
  
 
To examine the size and shape of the aggregates, a small sample was deposited on a TEM grid at 
elevated temperature in order for the structures to retain their formation. Figure S12 (A-C) shows 
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representative images from the sfGFP(S2)-polymer bioconjugates with all three PEGMAs. The 
presence of self-assembled structures at elevated temperatures further confirms the amphiphilic 
character of the bioconjugates at elevated temperatures. In addition, analysis of the double conjugated 
sgGFP(S2T216)-PEGMA2 by TEM (Figure S12D) indicates that larger particles (up to 400 nm) in 
addition to the smaller aggregates are present in solution at elevated temperature. This can be 
attributed to the higher polymer content in the double conjugate, and thus higher hydrophobic content 
of the bioconjugate. While the shape of the aggregates varies from spherical to lamellar, across the 
series of conjugates with different PEGMA lengths, we hypothesized these observations may be due 
to the challenging nature of the sample preparation at elevated temperature rather than an actual 
difference in morphology. 
 
Characterization of the bioconjugates by small-angle X-ray scattering 
Small-angle X-ray scattering (SAXS) measurements were carried out on the SAXS/WAXS beam line 
at the Australian Synchrotron facility at a photon energy of 11 keV. The samples were prepared in 
18.2 MΩ cm water and were run using a well-plate and a 1.5 mm diameter quartz capillary. The well-
plate and the capillary were held in a sample holder with temperature control achieved via a water 
bath connected to the sample holder. The measurements were collected at a sample to detector 
distance of 3.252 m to give a q range of 0.005 to 0.3 Å
-1
, where q is the scattering vector and is related 
to the scattering angle (2θ) and the photon wavelength (λ) by the following equation: 
  
     ( )
 
 
All patterns were normalised to fixed transmitted flux using a quantitative beam stop detector. The 
scattering from a blank (Tris buffer) was measured in the same location as sample collection and was 
subtracted for each measurement. The two-dimensional SAXS images were converted to one-
dimensional SAXS profile (I(q) versus q) by circular averaging, where I(q) is the scattering intensity. 
Both Igor with the NCNR analysis macro
7
 and Primus
8
 were used to analyse the data. This was 
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performed by using the Guinier law.
9
 At low q values (qRg < 1.3), Ln I(q) varies linearly as a function 
of q
2
 with a slope equal to Rg
2
/3. Moreover such a plot also extrapolates an estimation of the intensity 
at the origin I(0). Values of Rg were determined using two different software programs, with one also 
providing information on the general shape of the structure with the use of a dimension parameter, s 
(a value of 0 indicates a sphere whereas a value closer to 1 indicates an elongated morphology).
9,10
  
Table S3. SAXS analyses results for the sfGFP-PEGMA bioconjugates at 25 ºC. 
 Native sfGFP S2 T216 S2T216 
 
Rg = 2.1 nm 
s = 0.31 
- - - 
PEGMA-1 
Rg = 1.4 nm 
s = n/a
a
 
Rg = 2.0 nm 
s = 0.13 
Rg = 2.5 nm 
s = 0.10 
Rg = 2.2 nm 
s = 0.19 
PEGMA-2 
Rg = 1.5 nm 
s = 0.15 
Rg = 2.6 nm 
s = 0.09 
Rg = 2.3 nm 
s = 0.14 
n/a
 
PEGMA-3 
Rg = 1.2 nm 
s = 0.16 
Rg = 2.9 nm 
s = 0.21 
Rg = 3.1 nm 
s = 0.16 
Rg = 3.2 nm 
s = 0.17 
a
 Aggregation is observed and thus the calculation of the radius of gyration was not possible. 
Table S4. SAXS analyses results for the sfGFP-PEGMA bioconjugates at 65 ºC. 
 Native sfGFP S2 T216 S2T216 
No polymer 
Rg = 2.1 nm 
s = 0.24 
- - - 
PEGMA-1 
Rg = 1.7 nm 
s = 0.19 
Rg = 2.2 nm 
s = 0.29
a
 
Rg = 2.2 nm 
s = 0.36
a
 
Rg = 2.3 nm 
s = 0.42
a 
PEGMA-2 
Rg = 1.7 nm 
s = 0.11 
n/a 
Rg = 2.3 nm 
s = n/a
a 
n/a
 
PEGMA-3 
Rg = 1.8 nm 
s = 0.05 
Rg = 2.5 nm 
s = 0.30
a 
Rg = 2.5 nm 
s = 0.33
a 
Rg = 2.7 nm 
s = 0.15 
a
 Aggregation is observed and thus the calculation of the radius of gyration was not possible.  
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All protein bioconjugates display similar or higher Rg than the native sfGFP, as well as smaller s 
parameter, which indicates some sort of coiling of the polymer around the protein at 25 ºC and the 
formation of a more spherical morphology. At elevated temperature, 65 ºC, all protein bioconjugates 
display higher Rg than the sfGFP and higher s parameter; this indicates that the bioconjugate 
morphology is more elongated with the bioconjugation. The Rg also tends to increase for all sites of 
conjugation when the molecular weight of the polymer increases for both temperatures. The S2T216 
protein-conjugates surprisingly does not show an obvious increase of Rg compared to the single site 
protein-conjugate, which may indicate that complete double conjugation may not occur. This is in 
good correlation with the PAGE results (Figure 3). 
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Figure S13. Selected dimensionless Kratky plots at 25 °C. 
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Figure S14. Selected dimensionless Kratky plots at 65 °C. 
 
 
Figure S15. SAXS curves for PEGMA-1, native sfGPF and bioconjugate T216 + PEGMA-1 at 25 
and 65 °C. An important change of shape is observed for the PEGMA-1 data at low q values for the 
different temperature, which indicates aggregation. Almost no change of shape is observed for the 
sfGPF data at low q values at different temperature. A strong upturn is observed at low q values for 
the bioconjugate depending on the temperature. 
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